Author: Ian Cooper

CLSK Stock Price Stock Price in Uptrend With Clean Energy Push

CLSK Stock Price Stock Price in Uptrend With Clean Energy Push

Millions of Americans are dealing with extreme heat again. Along the way, it could fuel bigger demand for microgrids, and technology from companies like CleanSpark Inc. (CLSK).  According to The Guardian, “The heatwave gripping the US west is simultaneously breaking hundreds of temperature records, exacerbating a historic drought and priming the landscape for a summer […]

DKNG Stock Price Rebounds Slightly After Allegations of Black Market Activities

DKNG Stock Price Rebounds Slightly After Allegations of Black Market Activities

Draftkings Inc. (DKNG) is beginning to recover after a short report from Hindenburg Research. The short sellers allege that, “SBTech, a European technology company that merged with DKNG as part of the SPAC deal, generates significant revenue from questionable gambling practices in overseas markets, particularly in some Asian markets,” as reported by CNBC. However, DKNG […]

53495778 - science, chemistry, biology, medicine and people concept - close up of young scientists with pipette and flasks making test or research in clinical laboratory over hydrogen chemical formula

BIIB Stock Price Spikes On New Alzheimer’s Therapy Approval

Biogen’s (BIIB) stock price pushed higher this week the U.S. FDA approved its therapy for Alzheimer’s disease.  According to CNBC, “The FDA’s decision was highly anticipated as U.S. regulatory approval would make aducanumab the first drug approved to slow cognitive decline in people living with the disease and the first new medicine for Alzheimer’s in […]

Here’s Why FATE’s Stock Priced Popped

Here’s Why FATE’s Stock Priced Popped

FATE’s stock price was higher on Friday because Fate Therapeutics (FATE) highlighted positive interim data from its study of FT516 in combination with Rituximab for B-cell Lymphoma. “FT516 is the Company’s universal, off-the-shelf natural killer (NK) cell product candidate derived from a clonal master induced pluripotent stem cell (iPSC) line engineered with a novel high-affinity, […]

LAC Stock Price Jumps on Expansion News

LAC Stock Price Jumps on Expansion News

Keep an eye on lithium stocks, like Lithium Americas (LAC). All as lithium runs into a severe supply-demand situation again. All thanks to electric vehicle (EV) sales that are growing much faster than anyone expected. In fact, “By 2030, the world will see 125 million EVs on the road, which will only drive further demand […]

Close-up Of Person Hand Holding Small Plant On Stacked Coins

BYND Stock Price is Higher on Expansion News with KFC in China

Beyond Meat (BYND) is pushing aggressively higher. All after Bernstein analyst Alexia Howard raise her rating on BYND to an outperform rating, with a price target of $130.  “Consumer demand for meat alternatives overall have held up well on a two-year basis, and Beyond Meat itself is telling investors to expect a recovery in organic growth […]

NIO ES6 electric SUV semi-autonomous car on display near Chinese automobile manufacturer NIO software development office in Silicon Valley - San Jose, California, USA - 2019

Why NIO’s Stock Price Jumped Yesterday

Nio (NIO) is gaining traction again. Weeks ago, NIO reported April 2021 deliveries of 7,012 units, which represents 125.1% year over year growth. In addition, NIO reported first quarter revenue of $1.22 billion, which was up 481.8% year over year, and 20.2% quarter over quarter. [insert image: one of the NIO images we’ve not used […]

48447080 - bitcoin

Bitcoin Price Causes MSTR Stock Price to Drop

MicroStrategy (MSTR), which now owns more than 92,000 Bitcoins, fell $35 a share. All after Bitcoin plunged to less than $40,000. Fueling the pullback, China just “banned financial institutions and payment companies from providing services related to cryptocurrency transactions, and warned investors against speculative crypto trading,” says Reuters. Plus, weeks after fueling a Bitcoin rally […]

FATE Stock Price Moving on New Phase 1 Data

FATE Stock Price Moving on New Phase 1 Data

Just days ago, the company announced encouraging Interim Phase 1 Data for iPSC-derived NK cell programs in relapsed / refractory acute myeloid leukemia. “We are highly encouraged by these Phase 1 data in patients with relapsed / refractory AML, which clearly indicate that off-the-shelf, iPSC-derived NK cells administered as monotherapy in the outpatient setting were […]